Personalising radiotherapy dose in anal cancer (PLATO) Platform: 6-month patient reported outcomes across ACT3, ACT4 and ACT5 trials.

Gilbert A, Gaul C, Webster J, Brown SR, Copeland J, Ruddock S, Gilbert D, Hawkins MA, Muirhead R, Renehan AR, Abbott N, Berkman L, Norris M, Glynne-Jones R, Goh V, Rao S, Richman SD, Smith A, Adams R, Harrison M, Casanova N, Falk S, Stewart AJ, Sebag-Montefiore D.

Open source

DOI: 10.1016/j.radonc.2026.111706
Published: 2026-07-21
Container: Radiother Oncol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.radonc.2026.111706,
  title = {Personalising radiotherapy dose in anal cancer (PLATO) Platform: 6-month patient reported outcomes across ACT3, ACT4 and ACT5 trials.},
  author = {Gilbert A and  Gaul C and  Webster J and  Brown SR and  Copeland J and  Ruddock S and  Gilbert D and  Hawkins MA and  Muirhead R and  Renehan AR and  Abbott N and  Berkman L and  Norris M and  Glynne-Jones R and  Goh V and  Rao S and  Richman SD and  Smith A and  Adams R and  Harrison M and  Casanova N and  Falk S and  Stewart AJ and  Sebag-Montefiore D.},
  year = {2026},
  journal = {Radiother Oncol},
  doi = {10.1016/j.radonc.2026.111706},
  url = {https://doi.org/10.1016/j.radonc.2026.111706}
}

RIS

TY  - JOUR
TI  - Personalising radiotherapy dose in anal cancer (PLATO) Platform: 6-month patient reported outcomes across ACT3, ACT4 and ACT5 trials.
AU  - Gilbert A
AU  -  Gaul C
AU  -  Webster J
AU  -  Brown SR
AU  -  Copeland J
AU  -  Ruddock S
AU  -  Gilbert D
AU  -  Hawkins MA
AU  -  Muirhead R
AU  -  Renehan AR
AU  -  Abbott N
AU  -  Berkman L
AU  -  Norris M
AU  -  Glynne-Jones R
AU  -  Goh V
AU  -  Rao S
AU  -  Richman SD
AU  -  Smith A
AU  -  Adams R
AU  -  Harrison M
AU  -  Casanova N
AU  -  Falk S
AU  -  Stewart AJ
AU  -  Sebag-Montefiore D.
PY  - 2026
JO  - Radiother Oncol
DO  - 10.1016/j.radonc.2026.111706
UR  - https://doi.org/10.1016/j.radonc.2026.111706
ER  -

APA

A, G., C, G., J, W., SR, B., J, C., S, R., D, G., MA, H., R, M., AR, R., N, A., L, B., M, N., R, G., V, G., S, R., SD, R., A, S., R, A., M, H., N, C., S, F., AJ, S., & D., S. (2026). Personalising radiotherapy dose in anal cancer (PLATO) Platform: 6-month patient reported outcomes across ACT3, ACT4 and ACT5 trials.. Radiother Oncol. https://doi.org/10.1016/j.radonc.2026.111706

Source records

europe-pmc · retrieved 2026-09-26T05:24:03.242Z